Cargando…
Group treatment for complex dissociative disorders: a randomized clinical trial
BACKGROUND: Patients with complex dissociative disorders (CDD) report high levels of childhood- abuse experiences, clinical comorbidity, functional impairment, and treatment utilization. Although a few naturalistic studies indicate that these patients can benefit from psychotherapy, no randomized co...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112598/ https://www.ncbi.nlm.nih.gov/pubmed/35578194 http://dx.doi.org/10.1186/s12888-022-03970-8 |
_version_ | 1784709443137568768 |
---|---|
author | Bækkelund, Harald Ulvenes, Pål Boon-Langelaan, Suzette Arnevik, Espen Ajo |
author_facet | Bækkelund, Harald Ulvenes, Pål Boon-Langelaan, Suzette Arnevik, Espen Ajo |
author_sort | Bækkelund, Harald |
collection | PubMed |
description | BACKGROUND: Patients with complex dissociative disorders (CDD) report high levels of childhood- abuse experiences, clinical comorbidity, functional impairment, and treatment utilization. Although a few naturalistic studies indicate that these patients can benefit from psychotherapy, no randomized controlled trials have been reported with this patient-group. The current study evaluates a structured protocolled group treatment delivered in a naturalistic clinical setting to patients with CDD, as an add-on to individual treatment. METHODS: Fifty nine patients with CDD were randomized to 20 sessions of stabilizing group–treatment, conjoint with individual therapy, or individual therapy alone, in a delayed-treatment design. The treatment was based on the manual Coping with Trauma-Related Dissociation. The primary outcome was Global Assessment of Functioning (GAF), while secondary outcomes were PTSD and dissociative symptoms, general psychopathology, and interpersonal difficulties. RESULTS: Mixed effect models showed no condition x time interaction during the delayed treatment period, indicating no immediate differences between conditions in the primary outcome. Similar results were observed for secondary outcomes. Within-group effects were non-significant in both conditions from baseline to end of treatment, but significant improvements in psychosocial function, PTSD symptoms, and general psychopathology were observed over a 6-months follow-up period. CONCLUSION: In the first randomized controlled trial for the treatment of complex dissociative disorders, stabilizing group treatment did not produce immediate superior outcomes. Treatment was shown to be associated with improvements in psychological functioning. TRIAL REGISTRATION: Clinical Trials (NCT02450617). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-03970-8. |
format | Online Article Text |
id | pubmed-9112598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91125982022-05-18 Group treatment for complex dissociative disorders: a randomized clinical trial Bækkelund, Harald Ulvenes, Pål Boon-Langelaan, Suzette Arnevik, Espen Ajo BMC Psychiatry Research BACKGROUND: Patients with complex dissociative disorders (CDD) report high levels of childhood- abuse experiences, clinical comorbidity, functional impairment, and treatment utilization. Although a few naturalistic studies indicate that these patients can benefit from psychotherapy, no randomized controlled trials have been reported with this patient-group. The current study evaluates a structured protocolled group treatment delivered in a naturalistic clinical setting to patients with CDD, as an add-on to individual treatment. METHODS: Fifty nine patients with CDD were randomized to 20 sessions of stabilizing group–treatment, conjoint with individual therapy, or individual therapy alone, in a delayed-treatment design. The treatment was based on the manual Coping with Trauma-Related Dissociation. The primary outcome was Global Assessment of Functioning (GAF), while secondary outcomes were PTSD and dissociative symptoms, general psychopathology, and interpersonal difficulties. RESULTS: Mixed effect models showed no condition x time interaction during the delayed treatment period, indicating no immediate differences between conditions in the primary outcome. Similar results were observed for secondary outcomes. Within-group effects were non-significant in both conditions from baseline to end of treatment, but significant improvements in psychosocial function, PTSD symptoms, and general psychopathology were observed over a 6-months follow-up period. CONCLUSION: In the first randomized controlled trial for the treatment of complex dissociative disorders, stabilizing group treatment did not produce immediate superior outcomes. Treatment was shown to be associated with improvements in psychological functioning. TRIAL REGISTRATION: Clinical Trials (NCT02450617). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-022-03970-8. BioMed Central 2022-05-16 /pmc/articles/PMC9112598/ /pubmed/35578194 http://dx.doi.org/10.1186/s12888-022-03970-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Bækkelund, Harald Ulvenes, Pål Boon-Langelaan, Suzette Arnevik, Espen Ajo Group treatment for complex dissociative disorders: a randomized clinical trial |
title | Group treatment for complex dissociative disorders: a randomized clinical trial |
title_full | Group treatment for complex dissociative disorders: a randomized clinical trial |
title_fullStr | Group treatment for complex dissociative disorders: a randomized clinical trial |
title_full_unstemmed | Group treatment for complex dissociative disorders: a randomized clinical trial |
title_short | Group treatment for complex dissociative disorders: a randomized clinical trial |
title_sort | group treatment for complex dissociative disorders: a randomized clinical trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112598/ https://www.ncbi.nlm.nih.gov/pubmed/35578194 http://dx.doi.org/10.1186/s12888-022-03970-8 |
work_keys_str_mv | AT bækkelundharald grouptreatmentforcomplexdissociativedisordersarandomizedclinicaltrial AT ulvenespal grouptreatmentforcomplexdissociativedisordersarandomizedclinicaltrial AT boonlangelaansuzette grouptreatmentforcomplexdissociativedisordersarandomizedclinicaltrial AT arnevikespenajo grouptreatmentforcomplexdissociativedisordersarandomizedclinicaltrial |